Member Exclusive News

The week in industry: Novartis responds to FDA statement on data integrity of ZOLGENSMA®

This week: Automated sample preparation system for cryo-electron microscopy released, orphan drug designation granted for an investigational treatment for Dravet syndrome and exosome patents issued in Europe and the US.

Go to the profile of RxNet
Aug 08, 2019
0
0

Please sign in or register for FREE

No comments yet.